Fewer experiments.
More insight.
We build intelligent automation platforms that accelerate chemical process development.
Our tools reduce R&D, manufacturing, and commercial deployment costs for the pharmaceutical, critical minerals, and chemical industries.
Our
Company
Telescope is a chemical technology company developing scalable manufacturing processes and tools for the pharmaceutical and chemical industry. We build and deploy new enabling technologies including flexible robotic platforms and artificial intelligence software that improves experimental throughput, efficiency, and data quality. Our aim is to bring modern chemical technology solutions to meet the most serious challenges in health and sustainability.
The Team
Our award-winning scientific leadership includes a 2-time Nobel Prize Winner in Chemistry.
We have collectively authored over 450 academic publications and 34 patents.
PARTNERS
& CLIENTS
We partner with scientific instrumentation, pharmaceutical, mining and consulting engineering companies to resolve industry-driven challenges.
SCIENTIFIC
INSTRUMENTATION
COMPANIES
PHARMACEUTICAL
COMPANIES
MINING
COMPANIES
CONSULTING
ENGINEERING
COMPANIES
GOVERNMENT
AND ACADEMIA
BECOME A PARTNER!
Company News
Telescope Innovations Delivers Continued Strong Sales Revenue Growth in First Fiscal Quarter 2026
January 30, 2026 — The Company generated revenues of $2.7 million during this period.
Telescope Innovations Expands Lithium Development Infrastructure and Achieves Key Material Validation Milestones
January 27, 2026 — The Company is pleased to provide an update on the progress of its lithium processing...
Telescope Innovations Plans Expansion of DirectInject-LC™ Technology Ecosystem to Fuel the Physical AI Revolution
January 20, 2026 — Telescope is currently developing two new advanced analytical versions: DirectInject-IC™, and DirectInject-ICP™.
Telescope Innovations Outlines Global Market Opportunity for Self-Driving Labs and the Rising Adoption of Physical AI
January 5, 2026 — Telescope provides a strategic update regarding the accelerating commercial adoption of Self-Driving Labs (SDLs) and...
Telescope Innovations Reports Significant Milestones and Financial Results of Fiscal Year 2025
December 23, 2025 — The Company generated revenues of $5.8 million during FY25, with an Adjusted EBITDA loss of...
Telescope Innovations Installs Korea’s First Self-Driving Lab for Pharma R&D and Education
December 9, 2025 — Rapid three-week deployment, onsite support from two-time Nobel Laureate, and deep Canada-Korea collaboration underscore accelerating...
Telescope Innovations to deliver first Self-Driving Lab for Korea’s largest biopharma manufacturers association
November 17, 2025 — Korea’s leading biopharma association selects Telescope’s Self-Driving Lab to anchor the country’s first AI-driven training...
Telescope Innovations conditionally approved for up to $3.36 M in government funding to advance lithium processing technology
November 4, 2025 — Federal support accelerates Telescope’s continued development, demonstration and scale-up of lithium recycling and solid-state battery...
